Login Register Cart 0
Generic placeholder image

Combinatorial Chemistry & High Throughput Screening

Editor-in-Chief

ISSN (Print): 1386-2073
ISSN (Online): 1875-5402

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Comparative Proteomic Analysis Reveals Novel Biomarkers for Gastric Cancer in South Indian Tamil Population

Author(s): Ananthi Sivagnanam, Balasankar Thangasamy, Vignesh Nagarajan, Subeksha Govindarajan Ravi, Jeevitha Chithra Madhesh, Manikandan Athilinga Perumal, Premkumar Karunakaran and Megala Jayaraman*

Volume 25, Issue 8, 2022

Published on: 03 June, 2021

Page: [1361 - 1373] Pages: 13

DOI: 10.2174/1386207324666210603120320

Price: $65

Abstract

Background: Gastric Cancer (GC) remains a major global health problem due to a poor understanding of its progression at the molecular level and a lack of early detection or diagnosis. Early detection is highly crucial for improving prognosis. The incidence of GC is very high in countries, like India, due to the limitations among the established biomarkers for GC owing to poor sensitivity and specificity.

Objective: This study aimed to identify the novel biomarkers from serum samples obtained from GC patients compared to healthy subjects.

Methods: Serum samples from GC patients were analyzed by two-Dimensional Gel Electrophoresis (2DGE) coupled with tandem Mass Spectrometry (MS), including both Matrix-Assisted Laser Desorption/Ionization-Time of Flight (MALDI-ToF) and Liquid Chromatography-MS (LC-MS/MS) analysis. Identified proteins were further analyzed by gene ontology and protein interaction studies.

Results: A total of 73 protein spots were detected in 2DGE image analysis. Among them, seven differentially-expressed proteins were identified using MS analyses, including serotransferrin/ transferrin, albumin, ceruloplasmin, C-reactive protein (CRP), fibrinogen γ-chain (FGG), and two unreported novel proteins, immunoglobulin kappa constant (IgκC) region and Homo sapiens zinc finger protein 28 (ZNF28) homolog. Among these proteins, serotransferrin, albumin, ceruloplasmin, FGG, and ZNF28 were down-regulated in GC samples (p<0.05), while IgκC region and CRP were up-regulated significantly.

Conclusion: Most of the differentially expressed proteins were involved in angiogenesis, plasminogen-activating cascade, and blood coagulation pathways which are known to play a critical role in gastric tumorigenesis. Our current results provide a panel of candidate biomarkers for GC with novel biomarkers which have not been reported earlier.

Keywords: Gastric cancer, LC-MS/MS analysis, MALDI-ToF, proteomic analysis, serum biomarkers, gene ontology.

« Previous Next »
Graphical Abstract

[1]
Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin., 2018, 68(6), 394-424.
[http://dx.doi.org/10.3322/caac.21492] [PMID: 30207593]
[2]
Jemal, A.; Bray, F.; Center, M.M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics. CA Cancer J. Clin., 2011, 61(2), 69-90.
[http://dx.doi.org/10.3322/caac.20107] [PMID: 21296855]
[3]
Ebert, M.P.A.; Malfertheiner, P. Review article: Pathogenesis of sporadic and familial gastric cancer-implications for clinical management and cancer prevention. Aliment. Pharmacol. Ther., 2002, 16(6), 1059-1066.
[http://dx.doi.org/10.1046/j.1365-2036.2002.01288.x] [PMID: 12030946]
[4]
Hundahl, S.A.; Phillips, J.L.; Menck, H.R. The National Cancer Data Base Report on Poor Survival of U.S. Gastric Carcinoma Patients Treated with Gastrectomy 5th Edition American Joint Committee on Cancer Staging, Proximal Disease, and the “Different Disease” Hypothesis. Cancer, 2000, 88(4), 921-932.
[http://dx.doi.org/10.1002/(SICI)1097-0142(20000215)88:4<921:AID-CNCR24>3.0.CO;2-S]
[5]
Ucar, E.; Semerci, E.; Ustun, H.; Yetim, T.; Huzmeli, C.; Gullu, M. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer. Adv. Ther., 2008, 25(10), 1075-1084.
[http://dx.doi.org/10.1007/s12325-008-0100-4] [PMID: 18821070]
[6]
Liu, W.; Yang, Q.; Liu, B.; Zhu, Z. Serum proteomics for gastric cancer. Clin. Chim. Acta, 2014, 431, 179-184.
[http://dx.doi.org/10.1016/j.cca.2014.02.001] [PMID: 24525212]
[7]
Liu, X.; Cai, H.; Wang, Y. Prognostic significance of tumor markers in T4a gastric cancer. World J. Surg. Oncol., 2012, 10, 68.
[http://dx.doi.org/10.1186/1477-7819-10-68] [PMID: 22540862]
[8]
Umemura, H.; Togawa, A.; Sogawa, K.; Satoh, M.; Mogushi, K.; Nishimura, M.; Matsushita, K.; Tanaka, H.; Takizawa, H.; Kodera, Y.; Nomura, F. Identification of a high molecular weight kininogen fragment as a marker for early gastric cancer by serum proteome analysis. J. Gastroenterol., 2011, 46(5), 577-585.
[http://dx.doi.org/10.1007/s00535-010-0369-3] [PMID: 21298293]
[9]
Liu, C.; Pan, C.; Liang, Y. Screening and identification of serum proteomic biomarkers for gastric adenocarcinoma. Exp. Ther. Med., 2012, 3(6), 1005-1009.
[http://dx.doi.org/10.3892/etm.2012.515] [PMID: 22970007]
[10]
Fan, N.J.; Li, K.; Liu, Q.Y.; Wang, X.L.; Hu, L.; Li, J.T.; Gao, C.F. Identification of tubulin beta chain, thymosin beta-4-like protein 3, and cytochrome b-c complex subunit 1 as serological diagnostic biomarkers of gastric cancer. Clin. Biochem., 2013, 46(15), 1578-1584.
[http://dx.doi.org/10.1016/j.clinbiochem.2013.05.068] [PMID: 23747515]
[11]
Humphries, J.M.; Penno, M.A.; Weiland, F.; Klingler-Hoffmann, M.; Zuber, A.; Boussioutas, A.; Ernst, M.; Hoffmann, P. Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer. Biochim. Biophys. Acta, 2014, 1844(5), 1051-1058.
[http://dx.doi.org/10.1016/j.bbapap.2014.01.018] [PMID: 24512919]
[12]
Etemadi, A.; Safiri, S.; Sepanlou, S.G.; Ikuta, K.; Bisignano, C.; Shakeri, R.; Amani, M.; Fitzmaurice, C.; Nixon, M.; Abbasi, N.; Abolhassani, H. The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017. The LanGastroentero.&. Hepato, 2020, 5(1), 42-54.
[http://dx.doi.org/10.1016/S2468-1253(19)30328-0]
[13]
Servarayan Murugesan, C.; Manickavasagam, K.; Chandramohan, A.; Jebaraj, A.; Jameel, A.R.A.; Jain, M.S.; Venkataraman, J. Gastric cancer in India: epidemiology and standard of treatment. Updates Surg., 2018, 70(2), 233-239.
[http://dx.doi.org/10.1007/s13304-018-0527-3] [PMID: 29611052]
[14]
Shen, L.; Chen, C.; Yang, A.; Chen, Y.; Liu, Q.; Ni, J. Redox proteomics identification of specifically carbonylated proteins in the hippocampi of triple transgenic Alzheimer’s disease mice at its earliest pathological stage. J. Proteomics, 2015, 123, 101-113.
[http://dx.doi.org/10.1016/j.jprot.2015.04.005] [PMID: 25890254]
[15]
Ananthi, S.; Lakshmi, C.N.P.; Atmika, P.; Anbarasu, K.; Mahalingam, S. Global quantitative proteomics reveal deregulation of cytoskeletal and apoptotic signalling proteins in oral tongue squamous cell carcinoma. Sci. Rep., 2018, 8(1), 1567.
[http://dx.doi.org/10.1038/s41598-018-19937-3] [PMID: 29371635]
[16]
Ananthi, S.; Venkatesh Prajna, N.; Lalitha, P.; Valarnila, M.; Dharmalingam, K. Pathogen induced changes in the protein profile of human tears from Fusarium keratitis patients. PLoS One, 2013, 8(1), e53018.
[http://dx.doi.org/10.1371/journal.pone.0053018] [PMID: 23308132]
[17]
Ananthi, S.; Santhosh, R.S.; Nila, M.V.; Prajna, N.V.; Lalitha, P.; Dharmalingam, K. Comparative proteomics of human male and female tears by two-dimensional electrophoresis. Exp. Eye Res., 2011, 92(6), 454-463.
[http://dx.doi.org/10.1016/j.exer.2011.03.002] [PMID: 21396361]
[18]
Ananthi, S.; Chitra, T.; Bini, R.; Prajna, N.V.; Lalitha, P.; Dharmalingam, K. Comparative analysis of the tear protein profile in mycotic keratitis patients. Mol. Vis., 2008, 14, 500-507.
[PMID: 18385783]
[19]
Mi, H.; Huang, X.; Muruganujan, A.; Tang, H.; Mills, C.; Kang, D.; Thomas, P.D. PANTHER version 11: expanded annotation data from gene ontology and reactome pathways, and data analysis tool enhancements. Nucleic Acids Res., 2017, 45(D1), D183-D189.
[http://dx.doi.org/10.1093/nar/gkw1138] [PMID: 27899595]
[20]
Szklarczyk, D.; Franceschini, A.; Wyder, S.; Forslund, K.; Heller, D.; Huerta-Cepas, J.; Simonovic, M.; Roth, A.; Santos, A.; Tsafou, K.P.; Kuhn, M.; Bork, P.; Jensen, L.J.; von Mering, C. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res., 2015, 43(Database issue), D447-D452.
[http://dx.doi.org/10.1093/nar/gku1003] [PMID: 25352553]
[21]
Feng, J.T.; Liu, Y.K.; Song, H.Y.; Dai, Z.; Qin, L.X.; Almofti, M.R.; Fang, C.Y.; Lu, H.J.; Yang, P.Y.; Tang, Z.Y. Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis. Proteomics, 2005, 5(17), 4581-4588.
[http://dx.doi.org/10.1002/pmic.200401309] [PMID: 16240287]
[22]
Ryu, J.W.; Kim, H.J.; Lee, Y.S.; Myong, N.H.; Hwang, C.H.; Lee, G.S.; Yom, H.C. The proteomics approach to find biomarkers in gastric cancer. J. Korean Med. Sci., 2003, 18(4), 505-509.
[http://dx.doi.org/10.3346/jkms.2003.18.4.505] [PMID: 12923326]
[23]
Ren, H.; Du, N.; Liu, G.; Hu, H.T.; Tian, W.; Deng, Z.P.; Shi, J.S. Analysis of variabilities of serum proteomic spectra in patients with gastric cancer before and after operation. World J. Gastroenterol., 2006, 12(17), 2789-2792.
[http://dx.doi.org/10.3748/wjg.v12.i17.2789] [PMID: 16718772]
[24]
Fonseca-Nunes, A.; Agudo, A.; Aranda, N.; Arija, V.; Cross, A.J.; Molina, E.; Sanchez, M.J.; Bueno-de-Mesquita, H.B.; Siersema, P.; Weiderpass, E.; Krogh, V.; Mattiello, A.; Tumino, R.; Saieva, C.; Naccarati, A.; Ohlsson, B.; Sjöberg, K.; Boutron-Ruault, M.C.; Cadeau, C.; Fagherazzi, G.; Boeing, H.; Steffen, A.; Kühn, T.; Katzke, V.; Tjønneland, A.; Olsen, A.; Khaw, K.T.; Wareham, N.; Key, T.; Lu, Y.; Riboli, E.; Peeters, P.H.; Gavrila, D.; Dorronsoro, M.; Quirós, J.R.; Barricarte, A.; Jenab, M.; Zamora-Ros, R.; Freisling, H.; Trichopoulou, A.; Lagiou, P.; Bamia, C.; Jakszyn, P. Body iron status and gastric cancer risk in the EURGAST study. Int. J. Cancer, 2015, 137(12), 2904-2914.
[http://dx.doi.org/10.1002/ijc.29669] [PMID: 26135329]
[25]
Laskey, J.; Webb, I.; Schulman, H.M.; Ponka, P. Evidence that transferrin supports cell proliferation by supplying iron for DNA synthesis. Exp. Cell Res., 1988, 176(1), 87-95.
[http://dx.doi.org/10.1016/0014-4827(88)90123-1] [PMID: 3371425]
[26]
Koomen, J.M.; Shih, L.N.; Coombes, K.R.; Li, D.; Xiao, L.C.; Fidler, I.J.; Abbruzzese, J.L.; Kobayashi, R. Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins. Clin. Cancer Res., 2005, 11(3), 1110-1118.
[PMID: 15709178]
[27]
Ouyang, X.; Dang, Y.; Zhang, F.; Huang, Q. Low serum albumin correlates with poor survival in gastric cancer patients. Clin. Lab., 2018, 64.
[http://dx.doi.org/10.7754/Clin.Lab.2017.170804]
[28]
Lien, Y.C.; Hsieh, C.C.; Wu, Y.C.; Hsu, H.S.; Hsu, W.H.; Wang, L.S.; Huang, M.H.; Huang, B.S. Preoperative serum albumin level is a prognostic indicator for adenocarcinoma of the gastric cardia. J. Gastrointest. Surg., 2004, 8(8), 1041-1048.
[http://dx.doi.org/10.1016/j.gassur.2004.09.033] [PMID: 15585392]
[29]
Oñate-Ocaña, L.F.; Aiello-Crocifoglio, V.; Gallardo-Rincón, D.; Herrera-Goepfert, R.; Brom-Valladares, R.; Carrillo, J.F.; Cervera, E.; Mohar-Betancourt, A. Serum albumin as a significant prognostic factor for patients with gastric carcinoma. Ann. Surg. Oncol., 2007, 14(2), 381-389.
[http://dx.doi.org/10.1245/s10434-006-9093-x] [PMID: 17160496]
[30]
Alici, S.; Kaya, S.; Izmirli, M.; Tuncer, I. Doan, E.; Ozbek, H.; Sayarlioglu, H. Analysis of survival factors in patients with advanced-stage gastric adenocarcinoma. Med. Sci. Monit., 2006, 12(5), CR221-CR229.
[PMID: 16641880]
[31]
Lee, J.; Lim, T.; Uhm, J.E.; Park, K.W.; Park, S.H.; Lee, S.C.; Park, J.O.; Park, Y.S.; Lim, H.Y.; Sohn, T.S.; Noh, J.H.; Heo, J.S.; Park, C.K.; Kim, S.; Kang, W.K. Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinoma. Ann. Oncol., 2007, 18(5), 886-891.
[http://dx.doi.org/10.1093/annonc/mdl501] [PMID: 17298958]
[32]
Boonpipattanapong, T.; Chewatanakornkul, S. Preoperative carcinoembryonic antigen and albumin in predicting survival in patients with colon and rectal carcinomas. J. Clin. Gastroenterol., 2006, 40(7), 592-595.
[http://dx.doi.org/10.1097/00004836-200608000-00006] [PMID: 16917399]
[33]
Lai, C.C.; You, J.F.; Yeh, C.Y.; Chen, J.S.; Tang, R.; Wang, J.Y.; Chin, C.C. Low preoperative serum albumin in colon cancer: a risk factor for poor outcome. Int. J. Colorectal Dis., 2011, 26(4), 473-481.
[http://dx.doi.org/10.1007/s00384-010-1113-4] [PMID: 21190025]
[34]
Liu, J.; Chen, S.; Geng, Q.; Liu, X.; Kong, P.; Zhan, Y.; Xu, D. Prognostic value of pretreatment albumin-globulin ratio in predicting long-term mortality in gastric cancer patients who underwent D2 resection. OncoTargets Ther., 2017, 10, 2155-2162.
[http://dx.doi.org/10.2147/OTT.S99282] [PMID: 28458559]
[35]
Saito, H.; Kono, Y.; Murakami, Y.; Shishido, Y.; Kuroda, H.; Matsunaga, T.; Fukumoto, Y.; Osaki, T.; Ashida, K.; Fujiwara, Y. Postoperative serum albumin is a potential prognostic factor for older patients with gastric cancer. Yonago Acta Med., 2018, 61(1), 72-78.
[http://dx.doi.org/10.33160/yam.2018.03.010] [PMID: 29599625]
[36]
Sert, O.Z.; Bozkurt, H.; Bulut, I.C.; Uzun, O.; Gulmez, S.; Duman, M. C-Reactive protein to albumin ratio: A reliable marker in gastric cancer surgery. Indian J. Surg., 2020, 83, 92-99.
[http://dx.doi.org/10.1007/s12262-020-02310-y]
[37]
Schmidt, M.; Hellwig, B.; Hammad, S.; Othman, A.; Lohr, M.; Chen, Z.; Boehm, D.; Gebhard, S.; Petry, I.; Lebrecht, A.; Cadenas, C.; Marchan, R.; Stewart, J.D.; Solbach, C.; Holmberg, L.; Edlund, K.; Kultima, H.G.; Rody, A.; Berglund, A.; Lambe, M.; Isaksson, A.; Botling, J.; Karn, T.; Müller, V.; Gerhold-Ay, A.; Cotarelo, C.; Sebastian, M.; Kronenwett, R.; Bojar, H.; Lehr, H.A.; Sahin, U.; Koelbl, H.; Gehrmann, M.; Micke, P.; Rahnenführer, J.; Hengstler, J.G. A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin C as a compatible prognostic marker in human solid tumors. Clin. Cancer Res., 2012, 18(9), 2695-2703.
[http://dx.doi.org/10.1158/1078-0432.CCR-11-2210] [PMID: 22351685]
[38]
Li, M.; Feng, D.Y.; Ren, W.; Zheng, L.; Zheng, H.; Tang, M.; Cao, Y. Expression of immunoglobulin kappa light chain constant region in abnormal human cervical epithelial cells. Int. J. Biochem. Cell Biol., 2004, 36(11), 2250-2257.
[http://dx.doi.org/10.1016/j.biocel.2004.03.017] [PMID: 15313470]
[39]
Hu, D.; Duan, Z.; Li, M.; Jiang, Y.; Liu, H.; Zheng, H.; Li, L.; Bode, A.M.; Dong, Z.; Cao, Y. Heterogeneity of aberrant immunoglobulin expression in cancer cells. Cell. Mol. Immunol., 2011, 8(6), 479-485.
[http://dx.doi.org/10.1038/cmi.2011.25] [PMID: 21860405]
[40]
Liu, H.D.; Zheng, H.; Li, M.; Hu, D.S.; Tang, M.; Cao, Y. Upregulated expression of kappa light chain by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cells via NF-kappaB and AP-1 pathways. Cell. Signal., 2007, 19(2), 419-427.
[http://dx.doi.org/10.1016/j.cellsig.2006.07.012] [PMID: 16979873]
[41]
D’Errico, M.; de Rinaldis, E.; Blasi, M.F.; Viti, V.; Falchetti, M.; Calcagnile, A.; Sera, F.; Saieva, C.; Ottini, L.; Palli, D.; Palombo, F.; Giuliani, A.; Dogliotti, E. Genome-wide expression profile of sporadic gastric cancers with microsatellite instability. Eur. J. Cancer, 2009, 45(3), 461-469.
[http://dx.doi.org/10.1016/j.ejca.2008.10.032] [PMID: 19081245]
[42]
Hu, D.; Tong, S.; Wei, R.; Hui, Z.; Haidan, L.; Zhi, D.; Lili, L.; Wen, T.; Dan, Z.; Yanfeng, L.; Dongxin, L.; Ya, C. The polymorphisms on Igkappa gene are related to susceptibility of breast cancer and gastric cancer. Genet. Test., 2008, 12(4), 575-580.
[http://dx.doi.org/10.1089/gte.2008.0062] [PMID: 19072568]
[43]
Campos, D.; Freitas, D.; Gomes, J.; Magalhães, A.; Steentoft, C.; Gomes, C.; Vester-Christensen, M.B.; Ferreira, J.A.; Afonso, L.P.; Santos, L.L.; Pinto de Sousa, J.; Mandel, U.; Clausen, H.; Vakhrushev, S.Y.; Reis, C.A. Probing the O-glycoproteome of gastric cancer cell lines for biomarker discovery. Mol. Cell. Proteomics, 2015, 14(6), 1616-1629.
[http://dx.doi.org/10.1074/mcp.M114.046862] [PMID: 25813380]
[44]
Scanni, A.; Licciardello, L.; Trovato, M.; Tomirotti, M.; Biraghi, M. Serum copper and ceruloplasmin levels in patients with neoplasias localized in the stomach, large intestine or lung. Tumori, 1977, 63(2), 175-180.
[http://dx.doi.org/10.1177/030089167706300208] [PMID: 898288]
[45]
Scanni, A.; Tomirotti, M.; Licciardello, L.; Annibali, E.; Biraghi, M.; Trovato, M.; Fittipaldi, M.; Adamoli, P.; Curtarelli, G. Variations in serum copper and ceruloplasmin levels in advanced gastrointestinal cancer treated with polychemotherapy. Tumori, 1979, 65(3), 331-338.
[http://dx.doi.org/10.1177/030089167906500308] [PMID: 462583]
[46]
Misra, P.; Ghosh, A.K. Serum ceruloplasmin and serum adenosine deaminase: Do they have a role as a noninvasive diagnostic and follow up adjuncts in malignant solid tumors? Int. J. Contemp. Med. Res., 2018, 5(1), B1-B3.
[47]
Tsavaris, N.; Kosmas, C.; Kopterides, P.; Tsikalakis, D.; Skopelitis, H.; Sakelaridi, F.; Papadoniou, N.; Tzivras, M.; Balatsos, V.; Koufos, C.; Archimandritis, A. Retinol-binding protein, acute phase reactants and Helicobacter pylori infection in patients with gastric adenocarcinoma. World J. Gastroenterol., 2005, 11(45), 7174-7178.
[http://dx.doi.org/10.3748/wjg.v11.i45.7174] [PMID: 16437667]
[48]
Black, S.; Kushner, I.; Samols, D. C-reactive protein. J. Biol. Chem., 2004, 279(47), 48487-48490.
[http://dx.doi.org/10.1074/jbc.R400025200] [PMID: 15337754]
[49]
Gabay, C.; Kushner, I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med., 1999, 340(6), 448-454.
[http://dx.doi.org/10.1056/NEJM199902113400607] [PMID: 9971870]
[50]
Pepys, M.B.; Hirschfield, G.M. C-reactive protein: a critical update. J. Clin. Invest., 2003, 111(12), 1805-1812.
[http://dx.doi.org/10.1172/JCI200318921] [PMID: 12813013]
[51]
Allin, K.H.; Nordestgaard, B.G. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit. Rev. Clin. Lab. Sci., 2011, 48(4), 155-170.
[http://dx.doi.org/10.3109/10408363.2011.599831] [PMID: 22035340]
[52]
Chang, C.C.; Sun, C.F.; Pai, H.J.; Wang, W.K.; Hsieh, C.C.; Kuo, L.M.; Wang, C.S. Preoperative serum C-reactive protein and gastric cancer; clinical-pathological correlation and prognostic significance. Chang Gung Med. J., 2010, 33(3), 301-312.
[PMID: 20584508]
[53]
Yu, Q.; Yu, X.F.; Zhang, S.D.; Wang, H.H.; Wang, H.Y.; Teng, L.S. Prognostic role of C-reactive protein in gastric cancer: a meta-analysis. Asian Pac. J. Cancer Prev., 2013, 14(10), 5735-5740.
[http://dx.doi.org/10.7314/APJCP.2013.14.10.5735] [PMID: 24289571]
[54]
Shimura, T.; Kitagawa, M.; Yamada, T.; Ebi, M.; Mizoshita, T.; Tanida, S.; Kataoka, H.; Kamiya, T.; Joh, T. C-reactive protein is a potential prognostic factor for metastatic gastric cancer. Anticancer Res., 2012, 32(2), 491-496.
[PMID: 22287736]
[55]
Chen, Z.; Sun, Y.; Wang, J.; Shen, X.; Chen, L.; Zhuang, Z. Prognostic and predictive value of serum C-reactive protein levels in patients with metastatic or locally recurrent gastric cancer. Int. J. Biol. Markers, 2016, 31(3), e294-e299.
[http://dx.doi.org/10.5301/jbm.5000210] [PMID: 27174235]
[56]
Mao, M.; Wei, X.; Sheng, H.; Chi, P.; Liu, Y.; Huang, X.; Xiang, Y.; Zhu, Q.; Xing, S.; Liu, W. C-reactive protein/albumin and neutrophil/lymphocyte ratios and their combination predict overall survival in patients with gastric cancer. Oncol. Lett., 2017, 14(6), 7417-7424.
[http://dx.doi.org/10.3892/ol.2017.7179] [PMID: 29344182]
[57]
Kurokawa, Y.; Yamashita, K.; Kawabata, R.; Fujita, J.; Imamura, H.; Takeno, A.; Takahashi, T.; Yamasaki, M.; Eguchi, H.; Doki, Y. Prognostic value of postoperative C-reactive protein elevation versus complication occurrence: a multicenter validation study. Gastric Cancer, 2020, 23(5), 937-943.
[http://dx.doi.org/10.1007/s10120-020-01073-5] [PMID: 32314097]
[58]
Wu, C.; Luo, Z.; Chen, X.; Wu, C.; Yao, D.; Zhao, P.; Liu, L.; Shi, B.; Zhu, L. Two-dimensional differential in-gel electrophoresis for identification of gastric cancer-specific protein markers. Oncol. Rep., 2009, 21(6), 1429-1437.
[http://dx.doi.org/10.3892/or_00000371] [PMID: 19424620]
[59]
Duan, S.; Gong, B.; Wang, P.; Huang, H.; Luo, L.; Liu, F. Novel prognostic biomarkers of gastric cancer based on gene expression microarray: COL12A1, GSTA3, FGA and FGG. Mol. Med. Rep., 2018, 18(4), 3727-3736.
[http://dx.doi.org/10.3892/mmr.2018.9368] [PMID: 30106150]
[60]
Wang, H.; Meyer, C.A.; Fei, T.; Wang, G.; Zhang, F.; Liu, X.S. A systematic approach identifies FOXA1 as a key factor in the loss of epithelial traits during the epithelial-to-mesenchymal transition in lung cancer. BMC Genomics, 2013, 14, 680.
[http://dx.doi.org/10.1186/1471-2164-14-680] [PMID: 24093963]
[61]
Chen, C.; Zhang, L.G.; Liu, J.; Han, H.; Chen, N.; Yao, A.L.; Kang, S.S.; Gao, W.X.; Shen, H.; Zhang, L.J.; Li, Y.P.; Cao, F.H.; Li, Z.G. Bioinformatics analysis of differentially expressed proteins in prostate cancer based on proteomics data. OncoTargets Ther., 2016, 9, 1545-1557.
[http://dx.doi.org/10.2147/OTT.S98807] [PMID: 27051295]
[62]
Fan, B.L.; Zhu, W.L.; Zou, G.L.; Luo, G.S.; Xu, C.L.; Zhao, W.X. Cloning and identification of fibrinogen gamma polypeptide (FGG) gene differentially expressed in human hepatocellular carcinoma. Chin. J. Cancer, 2004, 23(3), 249-253.
[PMID: 15025951]
[63]
Bloomston, M.; Zhou, J.X.; Rosemurgy, A.S.; Frankel, W.; Muro-Cacho, C.A.; Yeatman, T.J. Fibrinogen gamma overexpression in pancreatic cancer identified by large-scale proteomic analysis of serum samples. Cancer Res., 2006, 66(5), 2592-2599.
[http://dx.doi.org/10.1158/0008-5472.CAN-05-3659] [PMID: 16510577]
[64]
Liu, Y.L.; Yan, Z.X.; Xia, Y.; Xie, X.Y.; Zhou, K.; Xu, L.L.; Shi, Y.L.; Wang, Q.; Bi, J.W. Ligustrazine reverts anthracycline chemotherapy resistance of human breast cancer by JAK2/STAT3 signaling inhibition and decreased fibrinogen gamma chain (FGG); Expression. Am. J.Can. Res, 2020.
[http://dx.doi.org/10.2139/ssrn.3420375]
[65]
Yano HKitayama, J.; Hatano, K.; Tsuno, N.; Osada, T.; Watanabe, T.; Tsuruo, T.; Muto, T.; Nagawa, H. Clustered cancer cells show a distinct adhesion behavior from single cell form under physiological shear conditions. J. Exp. Clin. Cancer Res., 2001, 20(3), 407-412.
[PMID: 11718222]
[66]
Nieswandt, B.; Hafner, M.; Echtenacher, B.; Männel, D.N. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res., 1999, 59(6), 1295-1300.
[PMID: 10096562]
[67]
Palumbo, J.S.; Kombrinck, K.W.; Drew, A.F.; Grimes, T.S.; Kiser, J.H.; Degen, J.L.; Bugge, T.H. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood, 2000, 96(10), 3302-3309.
[http://dx.doi.org/10.1182/blood.V96.10.3302] [PMID: 11071621]
[68]
Jen, J.; Wang, Y.C. Zinc finger proteins in cancer progression. J. Biomed. Sci., 2016, 23(1), 53.
[http://dx.doi.org/10.1186/s12929-016-0269-9] [PMID: 27411336]
[69]
Li, Y.; Zhao, Q.; Fan, L.Q.; Wang, L.L.; Tan, B.B.; Leng, Y.L.; Liu, Y.; Wang, D. Zinc finger protein 139 expression in gastric cancer and its clinical significance. World J. Gastroenterol., 2014, 20(48), 18346-18353.
[http://dx.doi.org/10.3748/wjg.v20.i48.18346] [PMID: 25561801]
[70]
Fan, L.; Tan, B.; Li, Y.; Zhao, Q.; Liu, Y.; Wang, D.; Zhang, Z. Silencing of ZNF139-siRNA induces apoptosis in human gastric cancer cell line BGC823. Int. J. Clin. Exp. Pathol., 2015, 8(10), 12428-12436.
[PMID: 26722429]
[71]
Li, Y.; Tan, B.B.; Zhao, Q.; Fan, L.Q.; Wang, D.; Liu, Y. ZNF139 promotes tumor metastasis by increasing migration and invasion in human gastric cancer cells. Neoplasma, 2014, 61(3), 291-298.https://scite.ai/reports/10.4149/neo_2014_037
[http://dx.doi.org/10.4149/neo_2014_037] [PMID: 24824930]
[72]
Li, Y.; Tan, B.B.; Zhao, Q.; Fan, L.Q.; Liu, Y.; Wang, D. Regulatory mechanism of ZNF139 in multi-drug resistance of gastric cancer cells. Mol. Biol. Rep., 2014, 41(6), 3603-3610.
[http://dx.doi.org/10.1007/s11033-014-3224-4] [PMID: 24515389]
[73]
Wu, S.; Lao, X.Y.; Sun, T.T.; Ren, L.L.; Kong, X.; Wang, J.L.; Wang, Y.C.; Du, W.; Yu, Y.N.; Weng, Y.R.; Hong, J.; Fang, J.Y. Knockdown of ZFX inhibits gastric cancer cell growth in vitro and in vivo via downregulating the ERK-MAPK pathway. Cancer Lett., 2013, 337(2), 293-300.
[http://dx.doi.org/10.1016/j.canlet.2013.04.003] [PMID: 23587796]
[74]
Yu, J.; Liang, Q.Y.; Wang, J.; Cheng, Y.; Wang, S.; Poon, T.C.W.; Go, M.Y.Y.; Tao, Q.; Chang, Z.; Sung, J.J.Y. Zinc-finger protein 331, a novel putative tumor suppressor, suppresses growth and invasiveness of gastric cancer. Oncogene, 2013, 32(3), 307-317.
[http://dx.doi.org/10.1038/onc.2012.54] [PMID: 22370639]
[75]
Liu, X.; Ge, X.; Zhang, Z.; Zhang, X.; Chang, J.; Wu, Z.; Tang, W.; Gan, L.; Sun, M.; Li, J. MicroRNA-940 promotes tumor cell invasion and metastasis by downregulating ZNF24 in gastric cancer. Oncotarget, 2015, 6(28), 25418-25428.
[http://dx.doi.org/10.18632/oncotarget.4456] [PMID: 26317898]
[76]
Ma, X.; Huang, M.; Wang, Z.; Liu, B.; Zhu, Z.; Li, C. ZHX1 Inhibits gastric cancer cell growth through inducing cell-cycle arrest and apoptosis. J. Cancer, 2016, 7(1), 60-68.
[http://dx.doi.org/10.7150/jca.12973] [PMID: 26722361]
[77]
Hui, H.X.; Hu, Z.W.; Jiang, C.; Wu, J.; Gao, Y.; Wang, X.W. ZNF418 overexpression protects against gastric carcinoma and prompts a good prognosis. OncoTargets Ther., 2018, 11, 2763-2770.
[http://dx.doi.org/10.2147/OTT.S160802] [PMID: 29785125]
[78]
Yajima, I.; Kumasaka, M.; Thang, N.D.; Yanagishita, T.; Ohgami, N.; Kallenberg, D.; Naito, Y.; Yoshikawa, T.; Sakashita, N.; Kato, M. Zinc finger protein 28 as a novel melanoma-related molecule. J. Dermatol. Sci., 2009, 55(1), 68-70.
[http://dx.doi.org/10.1016/j.jdermsci.2009.02.010] [PMID: 19329283]

Rights & Permissions Print Cite
Article Metrics
45
1
© 2024 Bentham Science Publishers | Privacy Policy